These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 21266263)

  • 1. Angiogenic factors and preeclampsia.
    Maynard SE; Karumanchi SA
    Semin Nephrol; 2011 Jan; 31(1):33-46. PubMed ID: 21266263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preeclampsia and angiogenic imbalance.
    Maynard S; Epstein FH; Karumanchi SA
    Annu Rev Med; 2008; 59():61-78. PubMed ID: 17937587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preeclampsia: the role of angiogenic factors in its pathogenesis.
    Wang A; Rana S; Karumanchi SA
    Physiology (Bethesda); 2009 Jun; 24():147-58. PubMed ID: 19509125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors.
    Tomimatsu T; Mimura K; Matsuzaki S; Endo M; Kumasawa K; Kimura T
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of hydrogen sulfide producing enzyme cystathionine γ-lyase contributes to maternal hypertension and placental abnormalities in preeclampsia.
    Wang K; Ahmad S; Cai M; Rennie J; Fujisawa T; Crispi F; Baily J; Miller MR; Cudmore M; Hadoke PW; Wang R; Gratacós E; Buhimschi IA; Buhimschi CS; Ahmed A
    Circulation; 2013 Jun; 127(25):2514-22. PubMed ID: 23704251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preeclampsia: new insights.
    Shah DM
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):213-20. PubMed ID: 17420664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular biology of preeclampsia.
    Myatt L; Webster RP
    J Thromb Haemost; 2009 Mar; 7(3):375-84. PubMed ID: 19087223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.
    Yagel S; Cohen SM; Goldman-Wohl D
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S963-S972. PubMed ID: 33712272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of preeclampsia.
    Young BC; Levine RJ; Karumanchi SA
    Annu Rev Pathol; 2010; 5():173-92. PubMed ID: 20078220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aetiology and physiopathology of preeclampsia and related forms.
    Lorquet S; Pequeux C; Munaut C; Foidart JM
    Acta Clin Belg; 2010; 65(4):237-41. PubMed ID: 20954461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New insights in the pathophysiology of preeclampsia and potential therapeutic implications].
    Boulanger H; Flamant M
    Nephrol Ther; 2007 Dec; 3(7):437-48. PubMed ID: 18047998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of placentation abnormalities in pregnancy-induced hypertension.
    Furuya M; Ishida J; Aoki I; Fukamizu A
    Vasc Health Risk Manag; 2008; 4(6):1301-13. PubMed ID: 19337544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
    Stepan H; Hund M; Andraczek T
    Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction.
    Fosheim IK; Jacobsen DP; Sugulle M; Alnaes-Katjavivi P; Fjeldstad HES; Ueland T; Lekva T; Staff AC
    Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100794. PubMed ID: 36334725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
    Tarca AL; Taran A; Romero R; Jung E; Paredes C; Bhatti G; Ghita C; Chaiworapongsa T; Than NG; Hsu CD
    Am J Obstet Gynecol; 2022 Jan; 226(1):126.e1-126.e22. PubMed ID: 34998477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preeclampsia and eclampsia: the conceptual evolution of a syndrome.
    Erez O; Romero R; Jung E; Chaemsaithong P; Bosco M; Suksai M; Gallo DM; Gotsch F
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S786-S803. PubMed ID: 35177220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenic factors and preeclampsia.
    Tjoa ML; Levine RJ; Karumanchi SA
    Front Biosci; 2007 Jan; 12():2395-402. PubMed ID: 17127249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.
    Rana S; Burke SD; Karumanchi SA
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1019-S1034. PubMed ID: 33096092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.